{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T16:23:32Z","timestamp":1648571012255},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,5,25]]},"DOI":"10.1001\/jama.2021.7716","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T15:34:01Z","timestamp":1621956841000},"page":"2039","source":"Crossref","is-referenced-by-count":0,"title":["Upadacitinib Noninferior to Adalimumab for Psoriatic Arthritis"],"prefix":"10.1001","volume":"325","author":[{"given":"Anita","family":"Slomski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2780330\/jama_slomski_2021_nt_210016_1621617379.30365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T15:34:02Z","timestamp":1621956842000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2780330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":0,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,5,25]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.7716","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,25]]}}}